ClinicalThought

Share

Program Content

Activities

  • FAQs: IO in HCC
    Immunotherapy in the Management of Patients With HCC: Answers to Frequently Asked Questions
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 24, 2024

    Expires: June 23, 2025

Faculty

cover img faculity

Richard S. Finn, MD

Professor
Department of Medicine
Division of Hematology/Oncology
UCLA David Geffen School of Medicine
Medical Director, Clinical Research Unit
Director, Signal Transduction and Therapeutics Program
University of California, Los Angeles
Los Angeles, California

cover img faculity

Sarah B. White, MD, MS, FSIR, FCIRSE

Professor of Radiology and Surgical Oncology
Vice Chair, Radiology Research
Associate Dean/Assistant Provost, Faculty Affairs
Senior Medical Director, Programmatic Excellence
Department of Radiology, Division of Vascular & Interventional Radiology
Medical College of Wisconsin
Milwaukee, Wisconsin

cover img faculity

Mark Yarchoan, MD

Associate Professor of Medical Oncology
Division of GI Malignancies
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University
Baltimore, Maryland

Provided by

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca